Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 2 3Phase 2/3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 6Leukemia 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Non-Hodgkin 4Recurrence 3Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Follicular 2Leukemia, T-Cell 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Congenital Abnormalities 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Small Cell Lung Carcinoma 1Seminoma 1Sarcoma, Ewing 1Retinoblastoma 1Primary Myelofibrosis 1Polycythemia Vera 1Neuroblastoma 1Neoplasms 1Myeloproliferative Disorders 1

Interventions

Paclitaxel 1Filgrastim 1Etoposide 1Drug Therapy 1Cisplatin 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Endodermal Sinus Tumor × Etoposide × Clear all
NCT00003643 2012-03-06

Combination Chemotherapy in Treating Men With Germ Cell Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Unknown
498 enrolled
Genitourinary

Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡